Nourianz for Parkinson's Disease User Reviews
- Par...
- Taken for 6 months to 1 year
- January 28, 2021
"Been taking Nourianz 20 mg for 8 months along with Rytary. Together, they have helped my rigidity. Have not experienced any side effects from either medication."
- Kel...
- Taken for 1 to 2 years
- February 26, 2024
"Good drug; had to stop taking it because of cost. Bummer, patent does not expire until 2027 - no competition."
See also:
Rytary
Rytary is used to treat symptoms of Parkinson's disease and parkinsonism that may follow carbon ...
Gocovri
Gocovri (amantadine) is used in the treatment of Parkinson's disease. Includes Gocovri side ...
Vyalev
Vyalev is a 24-hour infusion treatment for advanced Parkinson’s disease to help control symptoms. I ...
Onapgo
Onapgo is a wearable Infusion device used to help relieve motor fluctuations in adults with ...
Sinemet
Sinemet is used to treat symptoms of Parkinson's disease, such as muscle stiffness, tremors ...
Cogentin
Cogentin is used for extrapyramidal reaction, parkinson's disease
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
Rivastigmine
Rivastigmine is used for alzheimer's disease, lewy body dementia, parkinson's disease
Levodopa
Levodopa is used for parkinson's disease, parkinsonism, periodic limb movement disorder, restless ...
Amantadine
Easy-to-read patient leaflet for amantadine. Includes indications, proper use, special ...
Are you taking this medicine?
Your review helps others make informed decisions.Learn more about Parkinson's Disease
Care guides
Symptoms and treatments
Medicine.com guides (external)
More about Nourianz (istradefylline)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antiparkinson agents
- En español
"A useful medication - if you can afford it. Being on Medicare means you are on a 'government' plan, and you will get no assistance from any program. So once again, retirees are screwed by the drug companies that 'offer' assistance programs."